Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

Study ID: NCT06502691
Start Date: 2025-07-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

22

Intervention / Treatment

Best Practice

Biopsy of Breast

Computed Tomography

Electronic Health Record Review

Fludeoxyglucose F-18

Fluorine F 18 Fluorthanatrace

Immune Checkpoint Inhibitor

Poly (ADP-Ribose) Polymerase Inhibitor

Positron Emission Tomography

Positron Emission Tomography

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

Study ID: NCT04270591
Start Date: 2019-07-15
End Date: 2023-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

183

Intervention / Treatment

Glumetinib

Sponsor

Haihe biopharma co., ltd.

Source: clinicaltrials.gov

Share:
Add to list

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Study ID: NCT05629494
Start Date: 2022-09-27
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

198

Intervention / Treatment

Ibuprofen 400 mg, TID

PSA test

Sponsor

Albany Medical College

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Study ID: NCT05753501
Start Date: 2023-06-09
End Date: 2031-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

244

Intervention / Treatment

Abbv-101

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Study ID: NCT06239467
Start Date: 2024-02-26
End Date: 2027-08-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

150

Intervention / Treatment

OKI-219

Fulvestrant

Trastuzumab

Sponsor

OnKure, Inc.

Source: clinicaltrials.gov

Share:
Add to list

MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence

Study ID: NCT06323044
Start Date: 2025-02-11
End Date: 2029-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Best Practice

Biospecimen Collection

Electronic Health Record Review

Interview

Medical Device Usage and Evaluation

Medical Device Usage and Evaluation

Survey Administration

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Study ID: NCT04098744
Start Date: 2020-09-09
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Artesunate vaginal insert

Placebo vaginal insert

Sponsor

Frantz Viral Therapeutics, LLC

Source: clinicaltrials.gov

Share:
Add to list

Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm

Study ID: NCT06545344
Start Date: 2025-05-01
End Date: 2026-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Best Practice

Palliative Care Consultation

Survey Administration

Tumor Board Review

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging

Study ID: NCT04400292
Start Date: 2020-05-20
End Date: 2025-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Injection of indocyanine green (ICG)dye

Near-Infrared Image-Guided

Sentinel Lymph Node (SLN) mapping

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay

Study ID: NCT05870592
Start Date: 2023-08
End Date: 2024-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment
Sponsor

bioAffinity Technologies Inc.

Source: clinicaltrials.gov

Share:
Add to list